267P Irinotecan monotherapy as third line treatment for...

267P Irinotecan monotherapy as third line treatment for advanced gastric cancer patients refractory fluoropyrimidine, platinum and taxanes harboring UGT1A1*1/*1. *1/*6 or *1/*28

Sugimoto, N., Yoshinami, T., Yagi, T., Hasegawa, A., Fujisawa, F., Imamura, F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw582.048
Date:
December, 2016
File:
PDF, 70 KB
2016
Conversion to is in progress
Conversion to is failed